You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 24, 2025

Drug Price Trends for SENNA-TIME S TABLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SENNA-TIME S TABLET

Market Analysis and Price Projections for Senna-Time S Tablets

Introduction to Senna-Time S Tablets

Senna-Time S tablets, containing a combination of docusate and senna, are widely used as laxatives to treat constipation. These tablets are part of a broader market that includes various laxative products, each with its own market dynamics and growth projections.

Global Laxative Market Overview

The global laxative market, which includes products like Senna-Time S, is experiencing significant growth. This market was valued at USD 6.91 billion in 2023 and is projected to reach USD 11.26 billion by 2031, growing at a CAGR of 6.3% during the forecast period[3].

Specific Market for Sennosides

Within the laxative market, sennosides, the active ingredient in Senna-Time S tablets, hold a substantial share. The global sennosides market is expected to grow from US$ 359.5 million in 2023 to US$ 548.5 million by 2033, with a CAGR of 4.3% during this period. The sennosides segment dominates the market, accounting for around 71.7% of the global sennosides market, due to its easy availability and low cost[1].

Drivers of Market Growth

Several factors are driving the growth of the sennosides and laxative markets:

  • Increasing Prevalence of Gastrointestinal Disorders: The rise in constipation and other gastrointestinal disorders, partly due to sedentary lifestyles and low-fiber diets, is a significant driver. Constipation affects a substantial portion of the population and is often treated with laxatives like sennosides[1][3].
  • Expanding Geriatric Population: The growing elderly population is more prone to gastrointestinal issues, further increasing the demand for laxatives[3].

Dosage and Distribution

Senna-Time S tablets are preferred due to their easy administration and higher shelf life. The tablet segment, which includes Senna-Time S, held a revenue share of 67.7% in 2023 and is expected to grow at a CAGR of 4.2% during the forecast period[1].

Price Analysis

The cost of Senna-Time S tablets can vary depending on the pharmacy and location. Here are some price points:

  • Senna-Time S (50 mg-8.6 mg) oral tablet: Around $23 for a supply of 1000 tablets, or approximately $0.02 per unit[2].
  • Generic Version: Available at a lower price, around $10.82 for 100 tablets, or approximately $0.11 per unit[5].

Distribution Channels

Retail pharmacies are expected to witness the highest sales of sennosides, including Senna-Time S tablets, due to their widespread availability and consumer preference for purchasing medications from these outlets[1].

Regional Market Analysis

The global sennosides market is segmented across various regions, including North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa. Each region has its own market dynamics and growth prospects, with key countries such as the USA, China, and India playing significant roles[1].

Competitive Landscape

The market for sennosides and laxatives is competitive, with several key players operating in the space. Companies like Pharmaceutical Associates, Health and Herbs, and Now Foods are among the top players in the senna leaf extracts market, which is closely related to the sennosides market[4].

Regulatory Landscape

The regulatory environment plays a crucial role in the market for sennosides and laxatives. Regulatory frameworks vary by region and country, influencing the approval, distribution, and pricing of these products. Compliance with these regulations is essential for market participants[1].

Key Takeaways

  • The global sennosides market, which includes Senna-Time S tablets, is projected to grow at a CAGR of 4.3% from 2023 to 2033.
  • The tablet segment, which includes Senna-Time S, dominates the market due to its ease of administration and higher shelf life.
  • Retail pharmacies are the primary distribution channels for these products.
  • Increasing prevalence of gastrointestinal disorders and an expanding geriatric population are key drivers of market growth.
  • Prices for Senna-Time S tablets vary but are generally affordable, with generic versions available at lower costs.

FAQs

1. What is the projected market size for the global sennosides market by 2033? The global sennosides market is expected to reach US$ 548.5 million by 2033[1].

2. What is the primary driver of the sennosides market growth? The primary driver is the increasing prevalence of gastrointestinal disorders such as constipation[1][3].

3. How much does a supply of Senna-Time S tablets typically cost? A supply of 1000 Senna-Time S tablets can cost around $23, depending on the pharmacy[2].

4. Which distribution channel is expected to witness the highest sales of sennosides? Retail pharmacies are expected to witness the highest sales of sennosides, including Senna-Time S tablets[1].

5. What is the CAGR of the global laxative market from 2023 to 2031? The global laxative market is projected to grow at a CAGR of 6.3% from 2023 to 2031[3].

Cited Sources:

  1. Future Market Insights - Sennosides Market Size, Share, Trend & Outlook by 2033
  2. Drugs.com - Senna-Time S Prices, Coupons, Copay Cards & Patient Assistance
  3. Data Bridge Market Research - Global Laxative Market – Industry Trends and Forecast to 2031
  4. Business Research Insights - Senna Leaf Extracts Market Share | 2024 To 2031 Global Report
  5. Drugs.com - Docusate/senna Prices, Coupons, Copay Cards & Patient Assistance
Last updated: 2024-12-31

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.